URGENT PANDEMIC INFORMATION

In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List


TCR-based Therapies for Solid Tumors Summit 2022


Date
Jun 27, 2022 - 09:00 AM - Jun 29, 04:00 PM
Organizer
Hanson Wade
Venue
Hilton Boston Back Bay
Location
40 Dalton Street,

Boston,
MA,
US,
ZIP: 02115
Phone: +1 617 455 4188

Ticket Price: USD 2599.00 - USD 5097.00


Advancing Engineered, Native & Bispecific TCRs to Effectively Treat Solid Tumors
Do you want to gain unrivalled industry knowledge to build a first-class TCR-based therapy with high efficacy and targeting power in solid tumors?

The industry-leading TCR-based Therapies for Solid Tumors Summit returns for its third year to provide the perfect opportunity join the exclusive TCR community in Boston and uncover key learnings cross-industry in TCR discovery and selection to successfully target tumor-specific cells.

With the first commercial TCR therapy having reached approval, now is the perfect time to explore methods to discover novel targets and boost cell fitness to maximize the unparalleled benefits of these therapies in solid tumors.

Featuring 25 top-tier speakers, the TCR-based Therapies for Solid Tumors Summit will provide you with all the know-how needed to harness the power of TCRs.

Tickets    https://go.evvnt.com/1029444-2?pid=1052
Brochure https://go.evvnt.com/1029444-3?pid=1052

Prices:
Drug Developer Pricing - Conference + 2 Workshops - On the Door USD 4197.00
Drug Developer Pricing - Conference + 1 Workshop - On the Door USD 3598.00
Drug Developer Pricing - Conference Only - On the Door USD 2999.00
Standard Pricing - Conference + 2 Workshops - On the Door USD 5097.00
Standard Pricing - Conference + 1 Workshop - On the Door USD 4348.00
Standard Pricing - Conference Only - On the Door USD 3599.00
Academic Pricing - Conference + 2 Workshops - On the Door USD 3697.00
Academic Pricing - Conference + 1 Workshop - On the Door USD 3148.00
Academic Pricing - Conference Only - On the Door USD 2599.00

Category: Conferences | Science, Health & Medicine | Pharmaceuticals | Drug Development


Speaker Details


Adrian Rawcliffe CEO Adaptimmune, Helen Tayton-Martin CBO Adaptimmune, Karen Miller SVP, Pipeline Research Adaptimmune, Hugh Salter CSO Anocca, Piotr Pierog VP, Precision & Translational Medicine Affini-T Therapeutics, Reagan Jarvis CEO Anocca, Abhishek Srivastava VP, Cell Therapy Development Athenex, Dongxing Zha CTO, TCR Discovery & Engineering Alloy Therapeutics, Sungeun Kim Principal Scientist, Oncology Research Amgen, Cheng Liu Founder & CEO Eureka Therapeutics, Dan Macleod VP, Discovery ImmunoScape, Stefania Gobessi Director, Discovery Gadeta, Franco Marincola SVP, Global Head of Research Kite Pharma, Kathrin Davari Director Medigene, Parameswaran Hari SVP, Clinical Science Iovance Biotherapeutics, Aaron Vernon VP, Manufacturing TCR2 Therapeutics, Shannon Oda Assistant Professor Seattle Children’s Research Institute & University of Washington, Thomas Andresen CEO T-Cypher Bio, Andy Bader CSO Triumvira Immunologics, Cagan Gurer VP, Discovery TScan Therapeutics, Peggy Sotiropoulou CSO T-knife Therapeutics, Drew Deniger VP, Research & Development Ziopharm, Eduardo Davila Professor, Dept of Medicine University of Colorado Comprehensive Cancer Center, Garry Menzel President & CEO TCR2 Therapeutics, Marvin Gee VP, Target Discovery & Co-Founder, 3T Biosciences

Event Categories
Keywords: conference




Comments








Events Calendar

SunMonTueWedThuFriSat
29 30 31 1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 1 2

Newsletters

VIP Life Time Subscription to our Newsletters!
$399.99
$299.99